Richard Pazdur, MD, the longtime FDA drug regulator who abruptly left the agency in December, used his first public appearance at the J.P. Morgan Healthcare Conference this week to deliver a warning: the pharmaceutical industry is not taking concerns about
“Biotechs need flexibility and have limited budgets, while big pharma looks for long-term partnerships, reliability, scalability, and new technologies.” Luis Berrade, Senior Director of Global Biologics Testing Sales at Charles River Laboratories, has spent his career helping pharmaceutical and biotech
“Projects quite often realize too late that their R&D process cannot just be copy-pasted from the lab into the manufacturing facility.” Dr. Jenny Prange is Head of Project Management at the Regenerative Medicine Technologies Platform (RMTP) at Wyss Zurich, an
